***Territory is the Mid-South Region - LA, AR, and MO***
At AstraZeneca we don't just put the patient first - we put the patient and those affected by cancer at the very heart of everything we do. From families to caregivers, we make a positive difference for as many people as possible.
We have a broad pipeline of next-generation medicines is focused principally on four disease areas - breast, ovarian, lung, and hematological cancers. As well as other tumor types, these are being targeted through five key platforms - immunotherapy, the genetic drivers of cancer and resistance, DNA Damage Repair, HER2, and Antibody-Drug Conjugates, underpinned by personalized healthcare and biomarker technologies.
Do you have expertise in and passion for Medical Affairs in Oncology? Would you like to apply your expertise to impact the Medical Science Liaison/Sr. MSL's role in a company that follows the science and turns ideas into life-changing medicines?
Main Duties and Responsibilities
The Oncology Medical Science Liaison/Sr. (MSL), GU is a field-based professional with scientific, clinical, and therapeutic area expertise. You are responsible for providing medical and scientific support for AstraZeneca's oncology marketed products, new indications for current products, and compounds in development. The Oncology MSL engages in scientific exchange with targeted Key Opinion Leaders (KOLs), Key Decision Makers (KDMs), and Healthcare Professionals (HCPs) consistent with Medical Affairs and Therapeutic Brand Teams' objectives.
As an Oncology. MSL you will provide actionable information that enhances the value and appropriate use of AstraZeneca's products to internal stakeholders; respond to customer inquiries to ensure focused and balanced clinical and scientific information that supports the appropriate use of AstraZeneca's products and services and deliver appropriate clinical and scientific information that clinically differentiates AstraZeneca's products.
Additional accountabilities include adhering to internal standard processes and complying with regulatory and compliance requirements along with sustaining expertise in disease state management, emerging therapies, and the competitive landscape.